The present disclosure relates to endoluminal vascular prostheses and methods of placing such prostheses, and, in one application, to endoluminal vascular prostheses for use in the treatment of Type II endoleaks.
Stent grafts can be used for the endovascular treatment of aortic disease including aneurysms and dissections. The purpose of the stent graft is generally to isolate the diseased portion of the aortic wall from the aortic blood pressure and prevent further dilatation or rupture of the diseased portion of the aortic wall.
There also exists a type of endoleak that is independent of the stent graft 10. The leak is created by pressure differences in the lumbar arteries 5a, 5b.
Current stent graft systems do not address the issue of Type II endoleaks. Type II endoleaks are present in a considerable number of patients after stent graft placement. These endoleaks can potentially cause continuing dilatation and even rupture of the aneurysm in some patients.
Various strategies have been developed to manage Type II endoleaks. In general, patients are monitored and their aneurysms are imaged routinely to ensure stabilization of the aneurysm. In case of persistent Type II endoleaks associated with aneurysm dilatation, interventions are recommended to embolize the endoleak. Coils or fast-curing polymers can be injected into the aneurismal sac to thrombose the blood in the sac and stop the blood flow between the lumbar arteries.
There is a clear need to manage Type II endoleaks. The current invention proposes a novel design of a stent graft that eliminates Type II endoleaks at the time of stent graft placement.
Some embodiments described herein are directed to systems, methods and apparatuses for treating endovascular aneurysms or other endovascular defects such as Type II endoleaks (collectively referred to as “defects”). However, it will be appreciated that the systems, methods and apparatuses disclosed herein can be used in other fields or other portions of the body.
In some embodiments, such defects can be treated with a deployment system for deploying an endoluminal prosthesis within a passageway comprising a graft supported in a first position within a catheter and a stent supported in a second position within the catheter and configured to be expandable within the graft, wherein the first position does not overlap the second position. The stent can be self-expandable, balloon expandable, or expandable by other suitable means.
Some embodiments disclosed herein are directed to a stent graft system comprising a first stent graft having a first stent, a first inner graft supported by the first stent, a second inner graft supported by the first stent, and an outer graft. In some embodiments, the second inner graft can be spaced apart from the first inner graft so that a portion of the first stent is not covered by either the first inner graft or the second inner graft. A first portion and a second portion of the outer graft can be attached to the first stent, the outer graft being unsupported by the stent between the first and second portions so as to form a fillable space between the outer graft, the first inner graft, and the second inner graft. The stent graft system can further comprise a second stent graft deployable within the inside of the first stent graft so as to sealingly cover the uncovered portion of the first stent, the second stent graft having a second stent and a second graft and a length that is greater than a length of the uncovered portion of the first stent graft.
Some embodiments disclosed herein are directed to a stent graft system comprising a stent having a flow lumen therethrough, a first inner graft supported along at least a portion of the length of the stent, one or more openings formed through a wall of the first inner graft, one or more flap members configured to selectively cover the one or more openings formed through a wall of the first inner graft, and an outer graft positioned around the stent and configured to cover at least the one or more openings formed through the wall of the first inner graft. In some embodiments, the stent graft can be configured such that a substantially sealed space can be created between the outer graft and at least the first inner graft and the one or more flap members. The one or more flap members can be configured to permit blood to flow from the lumen through the openings into the space, and to at least inhibit the flow of blood from the space through the openings and into the lumen.
Some embodiments disclosed herein are directed to a method of treating a blood vessel with a stent graft, comprising positioning a first stent graft across the segment of the blood vessel to be treated, the first stent graft having a first stent, an inner graft having a first portion and a second portion, and an outer graft, filling the space between the inner graft and the outer graft through the uncovered portion of the stent with blood so that the outer graft expands outwardly away from the inner graft, and deploying a second stent graft inside the first stent graft so as to sealingly cover the uncovered portion of the first stent graft, the second stent graft having a second stent and a second graft. In some embodiments, the second portion of the inner graft can be spaced apart from the first portion of the inner graft so that a portion of the first stent can be uncovered by the inner graft, and a first portion and a second portion of the outer graft can be attached to at least one of the first stent and the inner graft. The outer graft can be unsupported by the first stent or inner graft between the first and second portions of the outer graft so as to create a fillable space between the outer graft and the inner graft.
Some embodiments disclosed herein are directed to a method of sealing a branch vessel with a stent graft, comprising positioning a first stent graft across the segment of the blood vessel to be treated, the first stent graft having a first stent, an inner graft having a first portion and a second portion, and an outer graft, filling the space between the inner graft and the outer graft through the uncovered portion of the stent with blood so that the outer graft expands outwardly away from the inner graft and covers an ostium to a branch vessel, and deploying a second stent graft inside the first stent graft so as to sealingly cover the uncovered portion of the first stent graft, the second stent graft having a second stent and a second graft. In some embodiments, the second portion of the inner graft can be spaced apart from the first portion of the inner graft so that a portion of the first stent is uncovered by the inner graft. Further, a first portion and a second portion of the outer graft can be attached to at least one of the first stent and the inner graft, the outer graft being unsupported by the first stent or inner graft between the first and second portions of the outer graft so as to create a fillable space between the outer graft and the inner graft.
Some embodiments disclosed herein are directed to a stent graft system comprising a stent, a first graft supported by the stent, and a second graft surrounding substantially all of an outside surface of the first graft. In some embodiments, the first graft is formed from a porous material and is sized to cover at least a portion of the length of the stent. A first portion and a second portion of the second graft can be attached to the first stent, the second graft being unsupported by the stent between the first and second portions so as to form a fillable space between the second graft and the first graft.
These and other features, aspects and advantages of the present disclosure will now be described in connection with non-exclusive embodiments, in reference to the accompanying drawings. The illustrated embodiments, however, are merely examples and are not intended to limit the invention. The following are brief descriptions of the drawings, which may not be drawn to scale.
This disclosure sets forth various embodiments of a novel stent graft system and method to reduce or eliminate Type II endoleaks. The design can also be used to improve the seal of stent grafts in difficult anatomical situations. The following detailed description is now directed to certain specific embodiments of the disclosure. In this description, reference is made to the drawings wherein like parts are designated with like numerals throughout the description and the drawings.
Some embodiments described herein are directed to systems, methods, and apparatuses to treat Type II endoleaks, lesions, aneurysms, or other defects in the aorta, including, but not limited to, the thoracic, ascending, and abdominal aorta, to name a few. However, the systems, methods, and apparatuses may have application to other vessels or areas of the body, or to other fields, and such additional applications are intended to form a part of this disclosure. For example, it will be appreciated that the systems, methods, and apparatuses may have application to the treatment of blood vessels in animals. In short, the embodiments and/or aspects of the endoluminal prosthesis systems, methods, and apparatuses described herein can be applied to other parts of the body or may have other applications apart from the treatment of the thoracic, ascending, and abdominal aorta. And, while specific embodiments may be described herein with regard to particular portions of the aorta, it is to be understood that the embodiments described are adaptable for use in other portions of the aorta or other portions of the body and are not limited to the aortic portions described.
The diameter of the outer graft cover 35 can be larger than that of the inner graft cover 34. In some embodiments, the outer graft cover 35 or any other outer graft cover embodiment disclosed herein can have a tubular shape, or can have a bulged middle portion such that the middle portion defines a greater diameter than the end portions of the outer graft cover 35. In some embodiments, the diameter of the outer graft cover 35 can be sufficiently large to expand to the flow lumen or against the inside surface of the aneurysm. The inner graft cover 34 and the outer graft cover 35 can be connected at the distal and proximal ends to form a sealed space 36. One or more openings 37, which can have any suitable size, large or small, can be cut or otherwise formed in the inner graft cover 34 to allow fluid communication between the inner lumen of the stent graft and the space 36.
In the embodiment described in
Further, in some embodiments, the inner graft can be a generally non-porous material having a plurality of openings formed therein along at least a portion, or all of, the length of the inner graft layer. In some embodiments, as will be described in greater detail below, the inner graft layer can have pores or openings that are configured to allow one directional fluid flow. For example, the pores or openings can permit fluid to flow from an inside lumen through the inner graft, through the openings or pores in the inner graft layer, and into the space between the inner and outer graft layers, while being configured to prevent the flow of fluid (e.g., blood) from flowing in the opposite direction. Any of the embodiments of the graft layers disclosed herein, including the inner graft layer described above, can be used with any of the stent graft embodiments described in this application. For example, in some embodiments, the porous or perforated inner graft layer described herein can be used with any of the stent or stent graft embodiments disclosed herein with appropriate modifications, as necessary. All of such combinations are contemplated as forming a part of this disclosure.
In some embodiments, the inner graft material can be configured such that the pores or openings thrombose after a particular duration of exposure to a patient's blood. In this arrangement, the pores or openings in the inner graft material will essentially be sealed, so as to substantially inhibit or prevent the flow of blood through such openings or pores after the thrombosis of such openings or pores occurs. For example, the openings or pores can be configured to thrombose or become substantially sealed after the blood thinning agent (such as heparin) that is typically administered during arterial repair or other vascular procedures is removed or diminished from the patient's blood stream, thereby sealing the blood within the space between the inner and outer grafts within such space.
In some embodiments, the circumference of the outer graft cover can be larger than that of the inner graft. The outer graft cover can be large enough to inflate to the size of the flow lumen in the diseased blood vessel. In some embodiments, a substantial portion of the outer graft cover can touch the wall of the blood vessel when inflated. In the case of an abdominal aortic aneurysm, the diameter of the outer graft cover can be from approximately 4 cm or less to approximately 8 cm. In the case of an iliac aneurysm, the diameter of the outer graft can be from approximately 2 cm or less to approximately 4 cm. In some embodiments, the outer graft cover can be configured to only cover a portion of the inner graft cover. In some embodiments, the outer graft cover can be configured to only cover the distal portion, the proximal portion, or the mid-section of the inner graft cover. In some embodiments, the outer graft cover can be configured to only cover a portion of the circumference of the inner graft cover.
Therefore, in some embodiments, a branch vessel adjacent to the outer graft layer 45 (for example, a lumbar or mesenteric artery) can facilitate the expansion of the outer graft layer against the inside surface of the vessel wall by reducing the pressure (Psac) within the space between the outer graft material and the vessel wall relative to the pressure within the aorta (Paorta). In this configuration, in some embodiments, the space 43 between the inner and outer layers can fill with blood from the aorta as the branch vessel reduces the pressure between the outer graft layer and the vessel wall, such that an additional instrument or medically administered injection of blood or fluid into (i.e., pressurization or inflation of) the space 43 may be avoided.
Type II endoleaks, as illustrated in
The concept of a second outer graft layer can also be applied to the stent grafting of challenging anatomies in which is it difficult to obtain a seal between the graft and the vessel wall. For example, the blood vessel may have local calcium deposit, thrombus, or sudden changes in the diameter. The stent connected to the inner graft layer may not allow the inner graft to continuously contact the wall along the seal line. In the following disclosure, additional embodiments and examples are presented to illustrate further benefits of the second outer graft layer configuration.
An outer graft cover 123 can be connected to or otherwise supported by the stent 121 at one or both ends. The outer graft cover 123 can have a constant diameter, or can have a varying diameter along a length thereof. In some embodiments, the middle portion of the outer graft cover 123 can define a larger diameter than one or more of the end portions of the outer graft cover 123. In some embodiments, the diameter of some or all of the outer graft cover 123 can be greater than the diameter of the first inner graft 122a and/or second inner graft 122b. The uncovered midsection 124 can provide for rapid filling of the outer graft cover 123 with the patient's blood, as is illustrated in
The concept of a second stent graft can also be applied to the embodiments described herein with regard to, without limitation,
With reference to
In some embodiments, the outer graft cover 153 can be placed on the outside of the stent 151 and inverted at the ends to partially cover the inside of the stent 152. The open stent segment 155 can be located close to one end of the stent graft system. In some embodiments, the outer graft cover 157 can be configured to only form a hem at one end of the stent 151.
The bifurcated graft 181 can have a main graft body portion 184, a first graft branch portion 185, and a second graft branch portion 186. Similarly, the stent 182 can have a main stent body portion 187, a first stent branch portion 188, and a second stent branch portion 189. The stent 182, or any other stent embodiment disclosed herein, can provide substantially continuous scaffolding along the length thereof, or can be formed in segments or discrete portions that can be interconnected directly to other stent segments portions or can be held in the desired position by attachment to the graft material. In some embodiments, the stent 182, or segments or portions thereof, can be sutured or otherwise attached to the graft 181. In some embodiments, as in the illustrated embodiment, the proximal portion 182a of the stent 182 can extend proximal to the proximal end 181a of the graft 181 so that such proximal portion 182a of the stent 182 is not covered by the graft 181.
One or more openings 190 can be formed in the graft 181. In the illustrated embodiment, one opening 190 is formed laterally through a side wall of the main graft body portion 184 of the graft 181. The opening 190 can be formed in any desired position of the graft 181. As illustrated, in some embodiments, the opening 190 can be positioned so that blood can flow through the one or more opening 190, similar to the openings 37 described above with reference to
With reference to
In some embodiments, the flap member 202 can be formed on or affixed to the main graft body portion 184 of the graft 181. Without limitation, the flap member 202 can cover a portion of the length of the stent 182 and all or a portion of the circumference of the stent 182. In some arrangements, the flap member 202 can be stitched, sutured, adhered, or otherwise attached to the outside surface of the main graft body portion 184 of the graft 181.
An outer graft member 212 can be positioned over an outside surface of the main graft body portion 184 and the second graft member 200. The outer graft member 212 can be sealingly fixed to the main graft body portion 184 and the second graft member 200 so that a substantially sealed space 214 is created between the outer graft member 212 and the main graft body portion 184 and/or the second graft member 200. The stent graft system 180 can be configured so that blood can pass from the inside of the main graft body 184 through the opening 190 and into the space 210 formed inside the outer graft member 212, but so that the tabbed portion 202 inhibits or substantially prevents blood from flowing from the space 214 back through the opening 190.
In this arrangement, similar to other embodiments described above, blood in the aorta can pass through the openings 190 into the space 214 formed inside the outer graft member 212, causing the outer graft cover 212 to inflate until it substantially fills or approximately completely fills an aneurysm sac. The blood in the space 214 can ultimately coagulate and form a thrombus.
The graft 181, second graft member 200, the outer graft member 212, or any other graft embodiment disclosed herein can be formed from PTFE, ePTFE, or any other suitable material. The stent 182, or any other stent embodiment disclosed herein, can be formed from Nitinol, stainless steel, a shape memory or heat activated material, or any other suitable material. The stent 182, or any other stent embodiment disclosed herein, can be self-expandable, balloon expandable, or expandable by any other mechanical or other means such as, without limitation, heat.
With reference to
The outer layer 234 can be formed from a substantially or completely impervious material having one or more channels or tubules 238 projecting away from the base layer, the tubules 238 each having an opening 240 in a distal end 238a thereof. The tubules 238 can be formed from a thin cylinder or cone of material so that the walls of said tubules 238 are tapered. The tubules 238 can be configured to permit fluid flow therethrough in only one direction (for example, in the direction indicated by arrow “F” in
The tubules 238 can have a thickness (represented by “T” in
In some embodiments, the diameter or size D of the openings 240 can range from approximately 20 μm or less to 2 mm or more, and can have a height H from approximately one half of the diameter D to 5 times the diameter D, and a thickness T from approximately 2 μm or less to approximately 100 μm or more. Further, depending on the desired flow rate through the inner graft 230 and number of tubules 238 formed in the inner graft 230, the tubules 238 can be spaced apart by distance “L” shown in
Thrombosis of the blood in the space between the inner graft cover and the outer graft cover can stop or significantly reduce the communication of the pressure in the flow lumen to the vessel wall. The blood in the space can coagulate and thrombose once the blood is stagnant. The coagulation process can be accelerated by placing a thrombotic agent into the space between the inner and outer graft cover. Suitable agents can include, but are not limited to, salts, silk, albumin, and fibrin. The agents can be placed in the space in powder form or coating of the inner surfaces of the inner and outer graft cover. The opening into the space can be treated with a thrombotic agent to seal off the opening after the outer graft cover has been inflated. For example, a section of the inner graft cover can be made from a woven or knitted porous silk fabric.
Although the inventions have been disclosed in the context of a preferred embodiments and examples, it will be understood by those skilled in the art that the present disclosure extends beyond the specifically disclosed embodiments to other alternative embodiments and/or uses of the invention and obvious modifications and equivalents thereof. In addition, while a number of variations of the invention have been shown and described in detail, other modifications, which are within the scope of this invention, will be readily apparent to those of skill in the art based upon this disclosure. It can be also contemplated that various combinations or subcombinations of the specific features and aspects of the embodiments can be made and still fall within the scope of the invention. Accordingly, it should be understood that various features and aspects of the disclosed embodiments can be combine with or substituted for one another in order to form varying modes of the disclosed invention. Thus, it can be intended that the scope of the present disclosure herein disclosed should not be limited by the particular disclosed embodiments described above.
This application is a continuation of U.S. patent application Ser. No. 14/461,308, filed on Aug. 15, 2014, which is a divisional of U.S. patent application Ser. No. 13/397,952, filed Feb. 16, 2012, now U.S. Pat. No. 8,821,564, which is a continuation of U.S. patent application Ser. No. 12/844,266, filed on Jul. 27, 2010, now U.S. Pat. No. 8,118,856, which claims priority benefit under 35 U.S.C. § 119(e) of U.S. Provisional Application No. 61/228,938, filed Jul. 27, 2009, and U.S. Provisional Application No. 61/248,105, filed Oct. 2, 2009, all of which applications are hereby incorporated by reference as if fully set forth herein.
Number | Name | Date | Kind |
---|---|---|---|
2127903 | Bowen | Aug 1938 | A |
2437542 | Krippendorf | May 1944 | A |
2845959 | Sidebotham | Aug 1958 | A |
2990605 | Demsyk | Jul 1961 | A |
3029819 | Starks | Apr 1962 | A |
3096560 | Liebig | Jul 1963 | A |
3769336 | Lee, Jr. et al. | Oct 1973 | A |
3805301 | Liebig | Apr 1974 | A |
3983083 | Kaetsu et al. | Sep 1976 | A |
3996938 | Clark, III | Dec 1976 | A |
4362156 | Feller, Jr. et al. | Dec 1982 | A |
4473067 | Schiff | Sep 1984 | A |
4497074 | Ray et al. | Feb 1985 | A |
4501263 | Harbuck | Feb 1985 | A |
4503568 | Madras | Mar 1985 | A |
4525157 | Vaillancourt | Jun 1985 | A |
4562596 | Kornberg | Jan 1986 | A |
4580568 | Gianturco | Apr 1986 | A |
4590068 | Berthet et al. | May 1986 | A |
4592754 | Gupte et al. | Jun 1986 | A |
4617932 | Kornberg | Oct 1986 | A |
4641653 | Rockey | Feb 1987 | A |
4650466 | Luther | Mar 1987 | A |
4756307 | Crownshield | Jul 1988 | A |
4800882 | Gianturco | Jan 1989 | A |
4816028 | Kapadia et al. | Mar 1989 | A |
4840940 | Sottiurai | Jun 1989 | A |
4856516 | Hillstead | Aug 1989 | A |
4878906 | Lindemann et al. | Nov 1989 | A |
4907336 | Gianturco | Mar 1990 | A |
4922905 | Strecker | May 1990 | A |
4950068 | Mizuta | Aug 1990 | A |
4981478 | Evard et al. | Jan 1991 | A |
4981947 | Tomagou et al. | Jan 1991 | A |
4994069 | Ritchrt et al. | Feb 1991 | A |
4994071 | MacGregor | Feb 1991 | A |
4998539 | Delsanti | Mar 1991 | A |
5015232 | Maglinte | May 1991 | A |
5019090 | Pinchuk | May 1991 | A |
5034001 | Garrison et al. | Jul 1991 | A |
5035706 | Giantureo et al. | Jul 1991 | A |
5041093 | Chu | Aug 1991 | A |
5064435 | Porter | Nov 1991 | A |
5078726 | Kreamer | Jan 1992 | A |
5102417 | Palmaz | Apr 1992 | A |
5104399 | Lazarus | Apr 1992 | A |
5104404 | Wolff | Apr 1992 | A |
5108424 | Hoffman, Jr. et al. | Apr 1992 | A |
5116349 | Aranyi | May 1992 | A |
5123917 | Lee | Jun 1992 | A |
5133732 | Wiktor | Jul 1992 | A |
5135535 | Kramer | Aug 1992 | A |
5135536 | Hillstead | Aug 1992 | A |
5145620 | Sakai et al. | Sep 1992 | A |
5147334 | Moss | Sep 1992 | A |
5156619 | Ehrenfeld | Oct 1992 | A |
5156620 | Pigott | Oct 1992 | A |
5178634 | Martinez | Jan 1993 | A |
5197976 | Herweck et al. | Mar 1993 | A |
5201757 | Heyn et al. | Apr 1993 | A |
5207960 | Moret de Rocheprise | May 1993 | A |
5211658 | Clouse | May 1993 | A |
5246452 | Sinnott | Sep 1993 | A |
5256141 | Gancheff et al. | Oct 1993 | A |
5275622 | Lazarus et al. | Jan 1994 | A |
5282860 | Matsuno et al. | Jan 1994 | A |
5282824 | Gianturco | Feb 1994 | A |
5304200 | Spaulding | Apr 1994 | A |
5314444 | Gianturco | May 1994 | A |
5314472 | Fontaine | May 1994 | A |
5316023 | Palmaz et al. | May 1994 | A |
5320602 | Karpeil | Jun 1994 | A |
5330500 | Song | Jul 1994 | A |
5330528 | Lazim | Jul 1994 | A |
5338298 | McIntyre | Aug 1994 | A |
5342387 | Summers | Aug 1994 | A |
5354308 | Simon et al. | Oct 1994 | A |
5360443 | Barone et al. | Nov 1994 | A |
5366504 | Andersen et al. | Nov 1994 | A |
5370683 | Fontaine | Dec 1994 | A |
5370691 | Samson | Dec 1994 | A |
5383892 | Cardon et al. | Jan 1995 | A |
5387235 | Chuter | Feb 1995 | A |
5397355 | Marin et al. | Mar 1995 | A |
5405377 | Cragg | Apr 1995 | A |
5415664 | Pinchuk | May 1995 | A |
5423886 | Arru et al. | Jun 1995 | A |
5425765 | Tiefenbrun et al. | Jun 1995 | A |
5443477 | Marin et al. | Aug 1995 | A |
5443498 | Fontaine | Aug 1995 | A |
5443500 | Sigwart | Aug 1995 | A |
5449372 | Schmaltz et al. | Sep 1995 | A |
5458575 | Wang | Oct 1995 | A |
5458615 | Klemm et al. | Oct 1995 | A |
5462530 | Jang | Oct 1995 | A |
5464419 | Glastra | Nov 1995 | A |
5464450 | Buscemi et al. | Nov 1995 | A |
5484444 | Braunschweiler et al. | Jan 1996 | A |
5489295 | Piplani et al. | Feb 1996 | A |
5496365 | Sgro | Mar 1996 | A |
5507767 | Maeda et al. | Apr 1996 | A |
5507769 | Marin et al. | Apr 1996 | A |
5507770 | Turk | Apr 1996 | A |
5507771 | Gianturco | Apr 1996 | A |
5514154 | Lau et al. | May 1996 | A |
5514379 | Weissleder et al. | May 1996 | A |
5522880 | Barone et al. | Jun 1996 | A |
5522881 | Lentz | Jun 1996 | A |
5522883 | Slater et al. | Jun 1996 | A |
5530528 | Houki et al. | Jun 1996 | A |
5534024 | Rogers et al. | Jul 1996 | A |
5545211 | An et al. | Aug 1996 | A |
5545118 | Fang | Sep 1996 | A |
5554180 | Turk | Sep 1996 | A |
5554181 | Das | Sep 1996 | A |
5562697 | Christiansen | Oct 1996 | A |
5562726 | Chuter | Oct 1996 | A |
5562727 | Turk et al. | Oct 1996 | A |
5562728 | Lazarus et al. | Oct 1996 | A |
5571173 | Parodi | Nov 1996 | A |
5575816 | Rudnick et al. | Nov 1996 | A |
5575818 | Pinchuk | Nov 1996 | A |
5578071 | Parodi | Nov 1996 | A |
5578072 | Barone et al. | Nov 1996 | A |
5591197 | Orth et al. | Jan 1997 | A |
5591198 | Boyle et al. | Jan 1997 | A |
5591199 | Porter et al. | Jan 1997 | A |
5591229 | Parodi | Jan 1997 | A |
5591230 | Horn et al. | Jan 1997 | A |
5593417 | Rhodes | Jan 1997 | A |
5604435 | Foo et al. | Feb 1997 | A |
5607445 | Summers | Mar 1997 | A |
5609625 | Piplani et al. | Mar 1997 | A |
5609627 | Goicoechea et al. | Mar 1997 | A |
5609628 | Keranen | Mar 1997 | A |
5628783 | Quiachon et al. | May 1997 | A |
5628786 | Banas et al. | May 1997 | A |
5628788 | Pinchuk | May 1997 | A |
5630829 | Lauterjung | May 1997 | A |
5630830 | Verbeek | May 1997 | A |
5632763 | Glastra | May 1997 | A |
5632772 | Alcime et al. | May 1997 | A |
5639278 | Dereume et al. | Jun 1997 | A |
5641373 | Shannon et al. | Jun 1997 | A |
5643171 | Bradshaw et al. | Jul 1997 | A |
5643278 | Wijay | Jul 1997 | A |
5643312 | Fischell et al. | Jul 1997 | A |
5647857 | Anderson et al. | Jul 1997 | A |
5649952 | Lam | Jul 1997 | A |
5651174 | Schwartz et al. | Jul 1997 | A |
5653727 | Wiktor | Aug 1997 | A |
5653743 | Martin | Aug 1997 | A |
5653746 | Schmitt | Aug 1997 | A |
5653747 | Dereume | Aug 1997 | A |
5662580 | Bradshaw et al. | Sep 1997 | A |
5662614 | Edoga | Sep 1997 | A |
5662675 | Polanskyj Stockert et al. | Sep 1997 | A |
5662700 | Lazarus | Sep 1997 | A |
5662701 | Plaia et al. | Sep 1997 | A |
5662702 | Keranen | Sep 1997 | A |
5662703 | Yurek et al. | Sep 1997 | A |
5665115 | Cragg | Sep 1997 | A |
5665117 | Rhodes | Sep 1997 | A |
5669880 | Solar | Sep 1997 | A |
5669924 | Shaknovich | Sep 1997 | A |
5669934 | Sawyer | Sep 1997 | A |
5674241 | Bley et al. | Oct 1997 | A |
5674276 | Andersen et al. | Oct 1997 | A |
5676685 | Razaivi | Oct 1997 | A |
5676696 | Marcade | Oct 1997 | A |
5676697 | McDonald | Oct 1997 | A |
5679400 | Tuch | Oct 1997 | A |
5681345 | Tuteneuer | Oct 1997 | A |
5681346 | Orth et al. | Oct 1997 | A |
5683448 | Cragg | Nov 1997 | A |
5683449 | Marcade | Nov 1997 | A |
5683450 | Goicoechea et al. | Nov 1997 | A |
5683451 | Lenker et al. | Nov 1997 | A |
5683452 | Barone et al. | Nov 1997 | A |
5683453 | Palmaz | Nov 1997 | A |
5690642 | Osborne et al. | Nov 1997 | A |
5690643 | Wijay | Nov 1997 | A |
5690644 | Yurek et al. | Nov 1997 | A |
5693066 | Rupp et al. | Dec 1997 | A |
5693084 | Chuter | Dec 1997 | A |
5693086 | Goicoechea et al. | Dec 1997 | A |
5693087 | Parodi | Dec 1997 | A |
5693088 | Lazarus | Dec 1997 | A |
5695516 | Fischell et al. | Dec 1997 | A |
5695517 | Marin et al. | Dec 1997 | A |
5697948 | Marin et al. | Dec 1997 | A |
5697968 | Rogers et al. | Dec 1997 | A |
5709703 | Lukic et al. | Jan 1998 | A |
5713917 | Leonhardt | Feb 1998 | A |
5716365 | Goicoechea et al. | Feb 1998 | A |
5716393 | Lindenberg et al. | Feb 1998 | A |
5718724 | Goicoechea et al. | Feb 1998 | A |
5718973 | Lewis et al. | Feb 1998 | A |
5720735 | Dorros | Feb 1998 | A |
5720776 | Chuter et al. | Feb 1998 | A |
5723004 | Dereume et al. | Mar 1998 | A |
5725535 | Hegde et al. | Mar 1998 | A |
5733303 | Israel et al. | Mar 1998 | A |
5733325 | Robinson et al. | Mar 1998 | A |
5746776 | Smith et al. | May 1998 | A |
5749880 | Banas et al. | May 1998 | A |
5752974 | Rhee et al. | May 1998 | A |
5755770 | Ravenscroft | May 1998 | A |
5755771 | Penn et al. | May 1998 | A |
5755777 | Chuter | May 1998 | A |
5769882 | Fogarty et al. | Jun 1998 | A |
5769885 | Quiachon et al. | Jun 1998 | A |
5769887 | Brown et al. | Jun 1998 | A |
5782855 | Lau et al. | Jul 1998 | A |
5782909 | Quiachon et al. | Jul 1998 | A |
5785679 | Abolfathi et al. | Jul 1998 | A |
5800407 | Eldor | Sep 1998 | A |
5800456 | Maeda et al. | Sep 1998 | A |
5800508 | Goicoechea et al. | Sep 1998 | A |
5800526 | Anderson et al. | Sep 1998 | A |
5810836 | Hussein et al. | Sep 1998 | A |
5824037 | Fogarty et al. | Oct 1998 | A |
5824039 | Piplani et al. | Oct 1998 | A |
5824040 | Cox et al. | Oct 1998 | A |
5824053 | Khosravi et al. | Oct 1998 | A |
5843160 | Rhodes | Dec 1998 | A |
5843162 | Inoue | Dec 1998 | A |
5843164 | Frantzen et al. | Dec 1998 | A |
5843167 | Dwyer et al. | Dec 1998 | A |
5846261 | Kotula et al. | Dec 1998 | A |
5851228 | Pinheiro | Dec 1998 | A |
5855565 | Bar-Cohen et al. | Jan 1999 | A |
5855599 | Wan | Jan 1999 | A |
5860998 | Robinson et al. | Jan 1999 | A |
5867432 | Toda | Feb 1999 | A |
5868783 | Tower | Feb 1999 | A |
5871536 | Lazarus | Feb 1999 | A |
5871537 | Holman et al. | Feb 1999 | A |
5874500 | Rhee et al. | Feb 1999 | A |
5879321 | Hill | Mar 1999 | A |
5879366 | Shaw et al. | Mar 1999 | A |
5891193 | Robinson et al. | Apr 1999 | A |
5893887 | Jayaraman | Apr 1999 | A |
5902334 | Dwyer et al. | May 1999 | A |
5906640 | Penn et al. | May 1999 | A |
5906641 | Thompson et al. | May 1999 | A |
5916263 | Goicoceha et al. | Jun 1999 | A |
5919225 | Lau et al. | Jul 1999 | A |
5925075 | Myers et al. | Jul 1999 | A |
5928279 | Shannon et al. | Jul 1999 | A |
5931866 | Frantzen | Aug 1999 | A |
5935161 | Robinson et al. | Aug 1999 | A |
5938696 | Goicoechea et al. | Aug 1999 | A |
5948018 | Dereume et al. | Sep 1999 | A |
5957901 | Mottola et al. | Sep 1999 | A |
5957973 | Quiachon et al. | Sep 1999 | A |
5961546 | Robinson et al. | Oct 1999 | A |
5961548 | Shmulewitz | Oct 1999 | A |
5980552 | Pinchasik et al. | Nov 1999 | A |
6001125 | Golds et al. | Dec 1999 | A |
6004347 | McNamara et al. | Dec 1999 | A |
6004348 | Banas et al. | Dec 1999 | A |
6007575 | Samuels | Dec 1999 | A |
6015431 | Thornton et al. | Jan 2000 | A |
6017363 | Hojeibane | Jan 2000 | A |
6022359 | Frantzen | Feb 2000 | A |
6027779 | Campbell et al. | Feb 2000 | A |
6027811 | Campbell et al. | Feb 2000 | A |
6030415 | Chuter | Feb 2000 | A |
6039749 | Marin et al. | Mar 2000 | A |
6039755 | Edwin et al. | Mar 2000 | A |
6039758 | Quiachon et al. | Mar 2000 | A |
6045557 | White et al. | Apr 2000 | A |
6051020 | Goicoechea et al. | Apr 2000 | A |
6053932 | Daniel et al. | Apr 2000 | A |
6053940 | Wijay | Apr 2000 | A |
6063113 | Kavteladze | May 2000 | A |
6070589 | Keith et al. | Jun 2000 | A |
6074398 | Leschinsky | Jun 2000 | A |
6077296 | Shokoohi et al. | Jun 2000 | A |
6077297 | Robinson et al. | Jun 2000 | A |
6083259 | Frantzen | Jul 2000 | A |
6086611 | Duffy et al. | Jul 2000 | A |
6090128 | Douglas | Jul 2000 | A |
6093203 | Uflacker | Jul 2000 | A |
6096053 | Bates | Aug 2000 | A |
6106548 | Reubin et al. | Aug 2000 | A |
6117167 | Goicoechea et al. | Sep 2000 | A |
6123715 | Amplatz | Sep 2000 | A |
6123722 | Fogarty et al. | Sep 2000 | A |
6123723 | Konya et al. | Sep 2000 | A |
6124523 | Banas et al. | Sep 2000 | A |
6126685 | Lenker et al. | Oct 2000 | A |
6129756 | Kugler et al. | Oct 2000 | A |
6139573 | Sogard et al. | Oct 2000 | A |
6152943 | Sawhney | Nov 2000 | A |
6152957 | Jang | Nov 2000 | A |
6165201 | Sawhney et al. | Dec 2000 | A |
6168610 | Marin et al. | Jan 2001 | B1 |
6171281 | Zhang | Jan 2001 | B1 |
6183481 | Lee et al. | Feb 2001 | B1 |
6183509 | Dibie | Feb 2001 | B1 |
6187034 | Frantzen | Feb 2001 | B1 |
6187036 | Shaolian | Feb 2001 | B1 |
6192944 | Greenhalgh | Feb 2001 | B1 |
6197049 | Shaolian et al. | Mar 2001 | B1 |
6203735 | Edwin et al. | Mar 2001 | B1 |
6214022 | Taylor et al. | Apr 2001 | B1 |
6221102 | Baker et al. | Apr 2001 | B1 |
6231562 | Khosravi et al. | May 2001 | B1 |
6231563 | White et al. | May 2001 | B1 |
6245099 | Edwin et al. | Jun 2001 | B1 |
6261316 | Shaolian et al. | Jul 2001 | B1 |
6267775 | Clerc et al. | Jul 2001 | B1 |
6273909 | Kugler et al. | Aug 2001 | B1 |
6280466 | Kugler et al. | Aug 2001 | B1 |
6280467 | Leonhardt | Aug 2001 | B1 |
6283991 | Cox et al. | Sep 2001 | B1 |
6299597 | Buscemi et al. | Oct 2001 | B1 |
6312407 | Zadno-Azizi et al. | Nov 2001 | B1 |
6312462 | McDermott et al. | Nov 2001 | B1 |
6325819 | Pavcnik et al. | Dec 2001 | B1 |
6344053 | Boneau | Feb 2002 | B1 |
6348066 | Pinchuk et al. | Feb 2002 | B1 |
6350278 | Lenker et al. | Feb 2002 | B1 |
6352553 | Van der Burg et al. | Mar 2002 | B1 |
6352561 | Leopold et al. | Mar 2002 | B1 |
6355060 | Lenker et al. | Mar 2002 | B1 |
6361557 | Gittings et al. | Mar 2002 | B1 |
6361637 | Martin et al. | Mar 2002 | B2 |
6375666 | Mische | Apr 2002 | B1 |
6375675 | Dehdashtian et al. | Apr 2002 | B2 |
6395017 | Dwyer et al. | May 2002 | B1 |
6395018 | Castaneda | May 2002 | B1 |
6395019 | Chobotov | May 2002 | B2 |
6398807 | Chouinard et al. | Jun 2002 | B1 |
6409750 | Hyodoh et al. | Jun 2002 | B1 |
6409757 | Trout, III et al. | Jun 2002 | B1 |
6413273 | Baum et al. | Jul 2002 | B1 |
6416474 | Penner et al. | Jul 2002 | B1 |
6416542 | Marcade et al. | Jul 2002 | B1 |
6432131 | Ravenscroft | Aug 2002 | B1 |
6432134 | Anson et al. | Aug 2002 | B1 |
6436135 | Goldfarb | Aug 2002 | B1 |
6440171 | Doubler et al. | Aug 2002 | B1 |
6464721 | Marcade et al. | Oct 2002 | B1 |
6475166 | Escano | Nov 2002 | B1 |
6475170 | Doron et al. | Nov 2002 | B1 |
6491719 | Fogrty et al. | Dec 2002 | B1 |
6500202 | Shaolian et al. | Dec 2002 | B1 |
6508833 | Pavcnick et al. | Jan 2003 | B2 |
6508835 | Shaolian et al. | Jan 2003 | B1 |
6511325 | Lalka et al. | Jan 2003 | B1 |
6514281 | Blaeser et al. | Feb 2003 | B1 |
6514282 | Inoue | Feb 2003 | B1 |
6517572 | Kugler et al. | Feb 2003 | B2 |
6517573 | Pollock et al. | Feb 2003 | B1 |
6520988 | Colombo et al. | Feb 2003 | B1 |
6524335 | Hartley et al. | Feb 2003 | B1 |
6524336 | Papazolgou | Feb 2003 | B1 |
6533763 | Schneiter | Mar 2003 | B1 |
6533811 | Ryan et al. | Mar 2003 | B1 |
6551350 | Thornton et al. | Apr 2003 | B1 |
6558396 | Inoue | May 2003 | B1 |
6558414 | Layne | May 2003 | B2 |
6562063 | Euteneurer et al. | May 2003 | B1 |
6565596 | White et al. | May 2003 | B1 |
6565597 | Fearnot et al. | May 2003 | B1 |
RE38146 | Palmaz et al. | Jun 2003 | E |
6572645 | Leonhardt | Jun 2003 | B2 |
6576009 | Ryan et al. | Jun 2003 | B2 |
6582460 | Cryer | Jun 2003 | B1 |
6585758 | Chouinard et al. | Jul 2003 | B1 |
6592614 | Lenker et al. | Jul 2003 | B2 |
6592615 | Marcade et al. | Jul 2003 | B1 |
6605294 | Sawhney | Aug 2003 | B2 |
6610087 | Zarbatany et al. | Aug 2003 | B1 |
6613073 | White et al. | Sep 2003 | B1 |
6614026 | Adamec | Sep 2003 | B1 |
6616675 | Evard et al. | Sep 2003 | B1 |
6626939 | Burnside et al. | Sep 2003 | B1 |
6638468 | Hill et al. | Oct 2003 | B1 |
6652579 | Cox et al. | Nov 2003 | B1 |
6669718 | Besselink | Dec 2003 | B2 |
6673042 | Samson et al. | Jan 2004 | B1 |
6673105 | Chen | Jan 2004 | B1 |
6689157 | Madrid et al. | Feb 2004 | B2 |
6692512 | Jang | Feb 2004 | B2 |
6695833 | Frantzen | Feb 2004 | B1 |
6695875 | Stelter et al. | Feb 2004 | B2 |
6699276 | Sogard et al. | Mar 2004 | B2 |
6706064 | Anson | Mar 2004 | B1 |
6719797 | Ferree | Apr 2004 | B1 |
6729356 | Baker et al. | May 2004 | B1 |
6730119 | Smalling | May 2004 | B1 |
6733523 | Shaolian et al. | May 2004 | B2 |
6748953 | Sherry et al. | Jun 2004 | B2 |
6756007 | Pletzer et al. | Jun 2004 | B2 |
6761733 | Chobotov et al. | Jul 2004 | B2 |
6767359 | Weadock | Jul 2004 | B2 |
6770091 | Richter et al. | Aug 2004 | B2 |
6818014 | Brown et al. | Nov 2004 | B2 |
6818018 | Sawhney | Nov 2004 | B1 |
6821292 | Pazienza et al. | Nov 2004 | B2 |
6858037 | Penn et al. | Feb 2005 | B2 |
6899728 | Phillips et al. | May 2005 | B1 |
6923829 | Boyle et al. | Aug 2005 | B2 |
6929661 | Bolduc et al. | Aug 2005 | B2 |
6932837 | Amplatz et al. | Aug 2005 | B2 |
6939371 | Kugler et al. | Sep 2005 | B2 |
6939377 | Jayaraman et al. | Sep 2005 | B2 |
6942691 | Chuter | Sep 2005 | B1 |
6942692 | Landau et al. | Sep 2005 | B2 |
6942693 | Chouinard et al. | Sep 2005 | B2 |
6953475 | Shaolian et al. | Oct 2005 | B2 |
6960217 | Bolduc | Nov 2005 | B2 |
6969373 | Schwartz et al. | Nov 2005 | B2 |
6981982 | Armstrong et al. | Jan 2006 | B2 |
6984244 | Perez et al. | Jan 2006 | B2 |
6994722 | DiCarlo | Feb 2006 | B2 |
7004964 | Thompson et al. | Feb 2006 | B2 |
7004967 | Chouinard et al. | Feb 2006 | B2 |
7014653 | Ouriel et al. | Mar 2006 | B2 |
7025779 | Elliott | Apr 2006 | B2 |
7029494 | Soun et al. | Apr 2006 | B2 |
7029496 | Rakos et al. | Apr 2006 | B2 |
7033389 | Sherry | Apr 2006 | B2 |
7063707 | Bose et al. | Jun 2006 | B2 |
7074213 | McGuckin, Jr. et al. | Jul 2006 | B2 |
7074236 | Rabkin et al. | Jul 2006 | B2 |
7094255 | Penn et al. | Aug 2006 | B2 |
7108715 | Lawrence-Brown et al. | Sep 2006 | B2 |
7122051 | Dallara et al. | Oct 2006 | B1 |
7122052 | Greenhalgh | Oct 2006 | B2 |
7125464 | Chobotov et al. | Oct 2006 | B2 |
7147660 | Chobotov et al. | Dec 2006 | B2 |
7160318 | Greenberg et al. | Jan 2007 | B2 |
7163715 | Kramer | Jan 2007 | B1 |
7175652 | Cook et al. | Feb 2007 | B2 |
7175657 | Khan et al. | Feb 2007 | B2 |
7189256 | Smith | Mar 2007 | B2 |
7192441 | Sherry | Mar 2007 | B2 |
7201770 | Johnson et al. | Apr 2007 | B2 |
7217255 | Boyle et al. | May 2007 | B2 |
7235095 | Haverkost et al. | Jun 2007 | B2 |
7241308 | Andreas et al. | Jul 2007 | B2 |
7244444 | Bates | Jul 2007 | B2 |
7261733 | Brown et al. | Aug 2007 | B1 |
7264631 | DeCarlo | Sep 2007 | B2 |
7264632 | Wright et al. | Sep 2007 | B2 |
7267685 | Butaric et al. | Sep 2007 | B2 |
7270675 | Chun et al. | Sep 2007 | B2 |
7314483 | Landau et al. | Jan 2008 | B2 |
7320703 | DiMatteo et al. | Jan 2008 | B2 |
7329414 | Fisher et al. | Feb 2008 | B2 |
7331980 | Dubrul et al. | Feb 2008 | B2 |
7347850 | Sawhney | Mar 2008 | B2 |
7402168 | Acosta et al. | Jul 2008 | B2 |
7435253 | Hartley et al. | Oct 2008 | B1 |
7476232 | Deal | Jan 2009 | B2 |
7491230 | Holman et al. | Feb 2009 | B2 |
7520895 | Douglas et al. | Apr 2009 | B2 |
7530988 | Evans et al. | May 2009 | B2 |
7553324 | Andreas et al. | Jun 2009 | B2 |
7572289 | Sisken et al. | Aug 2009 | B2 |
7588825 | Bell et al. | Sep 2009 | B2 |
7618408 | Yandell | Nov 2009 | B2 |
7623909 | Sanghera et al. | Nov 2009 | B2 |
7637932 | Bolduc et al. | Dec 2009 | B2 |
7651519 | Dittman | Jan 2010 | B2 |
7666220 | Evans et al. | Feb 2010 | B2 |
7666333 | Lanphere et al. | Feb 2010 | B2 |
7674284 | Melsheimer | Mar 2010 | B2 |
7682383 | Robin | Mar 2010 | B2 |
7691135 | Shaolian et al. | Apr 2010 | B2 |
7722657 | Hartley | May 2010 | B2 |
7727228 | Abboud et al. | Jun 2010 | B2 |
7766959 | DiMatteo et al. | Aug 2010 | B2 |
7790273 | Lee et al. | Sep 2010 | B2 |
7799046 | White et al. | Sep 2010 | B2 |
7803178 | Whirley et al. | Sep 2010 | B2 |
7833259 | Boatman | Nov 2010 | B2 |
7872068 | Khosravi et al. | Jan 2011 | B2 |
7879081 | DeMatteo et al. | Feb 2011 | B2 |
7897086 | Khairkhahan et al. | Mar 2011 | B2 |
7909794 | Briscoe et al. | Mar 2011 | B2 |
7910129 | Kennedy et al. | Mar 2011 | B2 |
8034100 | Shaolian et al. | Oct 2011 | B2 |
8118856 | Schreck et al. | Feb 2012 | B2 |
8216295 | Bemjamin et al. | Jul 2012 | B2 |
8568466 | Shaolian et al. | Oct 2013 | B2 |
8821564 | Schreck et al. | Sep 2014 | B2 |
20020049412 | Madrid et al. | Apr 2002 | A1 |
20020169497 | Wholey et al. | Nov 2002 | A1 |
20030004560 | Chobotov et al. | Jan 2003 | A1 |
20030014075 | Rosenbluth et al. | Jan 2003 | A1 |
20030051735 | Pavcnik et al. | Mar 2003 | A1 |
20030097169 | Brucker et al. | May 2003 | A1 |
20030194505 | Milbocker | Oct 2003 | A1 |
20030223957 | Schwartz et al. | Dec 2003 | A1 |
20030225453 | Murch | Dec 2003 | A1 |
20040016997 | Ushio | Jan 2004 | A1 |
20040098096 | Eton | May 2004 | A1 |
20040116997 | Taylor et al. | Jun 2004 | A1 |
20040167597 | Costantino et al. | Aug 2004 | A1 |
20040167618 | Shaolian et al. | Aug 2004 | A1 |
20040176832 | Hartley et al. | Sep 2004 | A1 |
20040186471 | Trieu | Sep 2004 | A1 |
20040193245 | Deem et al. | Sep 2004 | A1 |
20040215322 | Kerr | Oct 2004 | A1 |
20050004660 | Rosenbluth et al. | Jan 2005 | A1 |
20050027238 | Fago et al. | Feb 2005 | A1 |
20050038494 | Eidenschink | Feb 2005 | A1 |
20050058327 | Pieper | Mar 2005 | A1 |
20050059994 | Walak et al. | Mar 2005 | A1 |
20050060025 | Mackiewicz et al. | Mar 2005 | A1 |
20050080476 | Gunderson et al. | Apr 2005 | A1 |
20050090804 | Chobotov et al. | Apr 2005 | A1 |
20050113693 | Smith et al. | May 2005 | A1 |
20050113905 | Greenberg et al. | May 2005 | A1 |
20050119731 | Brucker et al. | Jun 2005 | A1 |
20050121120 | Van Dijk et al. | Jun 2005 | A1 |
20050155608 | Pavcnik et al. | Jul 2005 | A1 |
20050158272 | Whirley et al. | Jul 2005 | A1 |
20050159803 | Lad et al. | Jul 2005 | A1 |
20050165480 | Jordan et al. | Jul 2005 | A1 |
20050171598 | Schaeffer | Aug 2005 | A1 |
20050203206 | Trieu | Sep 2005 | A1 |
20050216047 | Kumoyama et al. | Sep 2005 | A1 |
20050220848 | Bates | Oct 2005 | A1 |
20050228480 | Douglas et al. | Oct 2005 | A1 |
20050240153 | Opie | Oct 2005 | A1 |
20050240258 | Bolduc et al. | Oct 2005 | A1 |
20050240260 | Bolduc | Oct 2005 | A1 |
20050271727 | Yao | Dec 2005 | A1 |
20060030911 | Letort | Feb 2006 | A1 |
20060074481 | Vardi et al. | Apr 2006 | A1 |
20060167538 | Rucker | Jul 2006 | A1 |
20060210635 | Laurent et al. | Sep 2006 | A1 |
20060212112 | Evans et al. | Sep 2006 | A1 |
20060233990 | Humphrey et al. | Oct 2006 | A1 |
20060233991 | Humphrey et al. | Oct 2006 | A1 |
20060292206 | Kim | Dec 2006 | A1 |
20070016243 | Ramaiah et al. | Jan 2007 | A1 |
20070027467 | Ortiz et al. | Feb 2007 | A1 |
20070050008 | Kim et al. | Mar 2007 | A1 |
20070055346 | Chu et al. | Mar 2007 | A1 |
20070142817 | Hurt | Jun 2007 | A1 |
20070150041 | Evans et al. | Jun 2007 | A1 |
20070156084 | Belhe et al. | Jul 2007 | A1 |
20070203571 | Kaplan et al. | Aug 2007 | A1 |
20070208367 | Fiorella et al. | Sep 2007 | A1 |
20070213804 | Schaeffer et al. | Sep 2007 | A1 |
20070213805 | Schaeffer et al. | Sep 2007 | A1 |
20070299497 | Shaolian et al. | Dec 2007 | A1 |
20080009936 | Kim et al. | Jan 2008 | A1 |
20080039923 | Taylor et al. | Feb 2008 | A1 |
20080132993 | Rasmussen | Jun 2008 | A1 |
20080172122 | Mayberry et al. | Jul 2008 | A1 |
20080187591 | Rhee et al. | Aug 2008 | A1 |
20080188923 | Chu | Aug 2008 | A1 |
20080215087 | Pavcnik et al. | Sep 2008 | A1 |
20080228259 | Chu | Sep 2008 | A1 |
20080253987 | Rehor et al. | Oct 2008 | A1 |
20080275536 | Zarins et al. | Nov 2008 | A1 |
20080288044 | Osborne | Nov 2008 | A1 |
20080294237 | Chu | Nov 2008 | A1 |
20080300672 | Kassab et al. | Dec 2008 | A1 |
20090068279 | Richard | Mar 2009 | A1 |
20090081275 | Rolfes et al. | Mar 2009 | A1 |
20090112305 | Goldmann et al. | Apr 2009 | A1 |
20090117070 | Daniloff et al. | May 2009 | A1 |
20090117188 | Gershkovich et al. | May 2009 | A1 |
20090216315 | Schreck et al. | Aug 2009 | A1 |
20090238815 | Udipi et al. | Sep 2009 | A1 |
20090259298 | Mayberry et al. | Oct 2009 | A1 |
20090287145 | Cragg et al. | Nov 2009 | A1 |
20090294049 | Udipi et al. | Dec 2009 | A1 |
20090318949 | Ganpath et al. | Dec 2009 | A1 |
20090319029 | Evans et al. | Dec 2009 | A1 |
20100004728 | Rao et al. | Jan 2010 | A1 |
20100004730 | Benjamin et al. | Jan 2010 | A1 |
20100036360 | Herbowy et al. | Feb 2010 | A1 |
20100094409 | Barker et al. | Apr 2010 | A1 |
20100100115 | Soetermans et al. | Apr 2010 | A1 |
20110054586 | Mayberry et al. | Mar 2011 | A1 |
20110054587 | Mayberry et al. | Mar 2011 | A1 |
20110054594 | Mayberry et al. | Mar 2011 | A1 |
Number | Date | Country |
---|---|---|
2220141 | Nov 1996 | CA |
2133530 | Jan 1999 | CA |
295 21 548 | Feb 1995 | DE |
295 21 776 | Feb 1995 | DE |
0 177 330 | Jun 1991 | EP |
0 596 145 | May 1994 | EP |
0 621 015 | Oct 1994 | EP |
0 659 389 | Jun 1995 | EP |
0 688 545 | Dec 1995 | EP |
0 689 806 | Jan 1996 | EP |
0 712 614 | May 1996 | EP |
0 732 088 | Sep 1996 | EP |
0 732 088 | Sep 1996 | EP |
0 740 928 | Nov 1996 | EP |
0 740 928 | Nov 1996 | EP |
0 747 020 | Dec 1996 | EP |
0 775 470 | May 1997 | EP |
0 782 841 | Jul 1997 | EP |
0 783 873 | Jul 1997 | EP |
0 783 873 | Jul 1997 | EP |
0 783 874 | Jul 1997 | EP |
0 783 874 | Jul 1997 | EP |
0 762 856 | Sep 1998 | EP |
0 880 948 | Dec 1998 | EP |
0 904 745 | Mar 1999 | EP |
0 974 314 | Jan 2000 | EP |
0 732 088 | Apr 2000 | EP |
1 054 648 | Nov 2000 | EP |
0 846 450 | Dec 2001 | EP |
0 846 449 | Jan 2002 | EP |
0 846 452 | Jan 2002 | EP |
1 214 020 | Jun 2002 | EP |
1 433 438 | Jun 2004 | EP |
1 181 901 | Nov 2005 | EP |
1 110 515 | Mar 2006 | EP |
0 828 461 | Jul 2006 | EP |
1 181 902 | Mar 2009 | EP |
1 038 606 | Jul 1998 | ES |
1038606 | Jul 1998 | ES |
2 834 199 | Jul 2003 | FR |
04-25755 | Jan 1992 | JP |
08-336597 | Dec 1996 | JP |
9-511160 | Nov 1997 | JP |
2000-500047 | Jan 2000 | JP |
2003-250907 | Sep 2003 | JP |
WO 9313825 | Jul 1993 | WO |
WO 9424961 | Nov 1994 | WO |
WO 9521592 | Aug 1995 | WO |
WO 9618427 | Jun 1996 | WO |
WO 9634580 | Nov 1996 | WO |
WO 9639999 | Dec 1996 | WO |
WO 9641589 | Dec 1996 | WO |
WO 9710757 | Mar 1997 | WO |
WO 9710777 | Mar 1997 | WO |
WO 9714375 | Apr 1997 | WO |
WO 9719652 | Jun 1997 | WO |
WO 9726936 | Jul 1997 | WO |
WO 9729716 | Aug 1997 | WO |
WO 97033532 | Sep 1997 | WO |
WO 97045072 | Dec 1997 | WO |
WO 9802100 | Jan 1998 | WO |
WO 9841167 | Sep 1998 | WO |
WO 9853761 | Dec 1998 | WO |
WO 99029262 | Jun 1999 | WO |
WO 9944536 | Sep 1999 | WO |
WO 9947077 | Sep 1999 | WO |
WO 9958084 | Nov 1999 | WO |
WO 0051522 | Sep 2000 | WO |
WO 0166038 | Sep 2001 | WO |
WO 0187184 | Nov 2001 | WO |
WO 0193782 | Dec 2001 | WO |
WO 0200139 | Jan 2002 | WO |
WO 02102282 | Dec 2002 | WO |
WO 04037116 | May 2004 | WO |
WO 04045393 | Jun 2004 | WO |
WO 05037076 | Apr 2005 | WO |
WO 07000790 | Jan 2007 | WO |
WO-2008107885 | Sep 2008 | WO |
Entry |
---|
US 6,413,270 B1, 07/2002, Thornton et al. (withdrawn) |
European Extended & Supplemental Searth Report re EP App. No. 10806904.8, dated Nov. 13, 2012. |
Harris, J. Milton et al., Poly (ethylene glycol) Chemistry and Biological Applications, ACS Symposium Series, American Chemical Society, Washington DC, Developed from a symposium sponsored by the Division of Polymer Chemistry, Inc., at the 213th National Meeting of the American Chemical Society, San Francisco, CA, Apr. 13-17, 1997, Chapter 1; 12 pages. |
International Search Report and Written Opinion re PCT/US2010/043432, dated Apr. 22, 2011. |
Menger, et al., “Quantitative analysis of neovascularization of different PTEE-implants,” European Journal of Cardiothoracic Surgery, (1990) 4:191-196. |
Final Office Action dated Nov. 3, 2016, from U.S. Appl. No. 14/461,308. |
Final Office Action dated Oct. 27, 2015, from U.S. Appl. No. 14/461,308. |
International Report on Patentability and Written Opinion for PCT/US2010/043432, dated Jan. 31, 2012, dated Feb. 9, 2012. |
Non-final Office Action dated Apr. 16, 2015, from U.S. Appl. No. 14/461,308. |
Non-final Office Action dated Apr. 21, 2016, from U.S. Appl. No. 14/461,308. |
Number | Date | Country | |
---|---|---|---|
20180193131 A1 | Jul 2018 | US |
Number | Date | Country | |
---|---|---|---|
61228938 | Jul 2009 | US | |
61248105 | Oct 2009 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 13397952 | Feb 2012 | US |
Child | 14461308 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 14461308 | Aug 2014 | US |
Child | 15911629 | US | |
Parent | 12844266 | Jul 2010 | US |
Child | 13397952 | US |